Početna stranicaHLUN-A • CPH
add
H Lundbeck A/S Class A
Preth. zaklj. cijena
29,05 kr
Dnevni raspon
29,05 kr - 30,70 kr
Godišnji raspon
23,30 kr - 41,70 kr
Tržišna kapitalizacija
34,54 mlr. DKK
Prosječna količina
119,00 tis.
P/E omjer
-
Prinos dividende
-
Glavno tržište vrijednosnica
CPH
Vijesti s tržišta
Financijski podaci
Račun dobiti i gubitka
Prihod
Neto dohodak
| (DKK) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Prihod | 6,24 mlr. | 17,91 % |
Operativni troškovi | 3,45 mlr. | 15,06 % |
Neto dohodak | 1,15 mlr. | 14,51 % |
Neto profitabilnost | 18,48 | −2,84 % |
Zarada po dionici | 1,53 | 10,87 % |
EBITDA | 2,14 mlr. | 22,79 % |
Efektivna porezna stopa | 22,00 % | — |
Bilanca stanja
Ukupna imovina
Ukupne obveze
| (DKK) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Gotovinska i kratkoročna ulaganja | 2,70 mlr. | −47,25 % |
Ukupna imovina | 54,22 mlr. | 43,24 % |
Ukupne obveze | 29,65 mlr. | 92,31 % |
Ukupni kapital | 24,57 mlr. | — |
Dionice u optjecaju | 991,90 mil. | — |
Cijena prema knjigovodstvenoj vrijednosti | 1,17 | — |
Povrat imovine | 7,64 % | — |
Povrat kapitala | 10,42 % | — |
Tok novca
Neto promjena novca
| (DKK) | ožu 2025.info | Godišnja promjena |
|---|---|---|
Neto dohodak | 1,15 mlr. | 14,51 % |
Gotovina od poslovanja | 632,00 mil. | −34,24 % |
Gotovina iz ulaganja | −111,00 mil. | −18,09 % |
Gotovina iz financiranja | −2,48 mlr. | −226,32 % |
Neto promjena novca | −1,97 mlr. | −2.009,71 % |
Slobodan tok novca | −544,88 mil. | −180,75 % |
Više
H. Lundbeck A/S, commonly referred to as Lundbeck, is a Danish international pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at brain diseases, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease and migraine.
Headquartered in Copenhagen, Denmark, Lundbeck has approximately 5,600 employees in more than 50 countries, and their products are registered in more than 100 countries. They have production facilities in Denmark, France and Italy and their research centers are based in Denmark and the US.
Lundbeck is listed on the Copenhagen Stock Exchange.
Lundbeck is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations Wikipedia
Glavni izvršni direktor
Osnovano
14. kol 1915.
Web-lokacija
Zaposlenici
5.700
